Biologics

A Hartford, Conn.-based insurer has dropped its lawsuit that aimed to avoid defending Aziyo Biologics in litigation over tainted spine allografts.

Bone Biologics and the University of California Los Angeles plan to begin their joint venture clinical trial testing the efficacy of their bone graft substitute treatment for spinal fusion, trauma, osteoporosis and other bone-related indications in 2023.

Janet Conway, MD, completed the first U.S. cases using Bonesupport's Cerament G for osteomyelitis.

Orthobiologics company Ossio closed a $38.5 million series C financing round.

Here are six key updates in regenerative medicine since Oct. 1:

Orthofix launched its Legacy demineralized bone matrix, and Alan Daniels, MD, performed the first case with it.

ChitogenX launched its second orthopedic development program in meniscus repair, the orthobiologics company said Oct. 13.

Aziyo Biologics promoted leadership and added new hires on its team, the company said Oct. 11.

Westminster, Colo.-based orthobiologics company Cerapedics has appointed Valeska Schroeder as its new CEO, effective Nov. 1. 

Three babies have been born after UC Davis Health providers performed the first spina bifida treatment combining surgery with stem cells.